Stay updated with breaking news from Dthera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tinengotinib has been awarded orphan drug designation from the European Medicines Agency for use in select patients with biliary tract cancer.
MHealth Monitoring Diagnostic Medical Devices Market to Reach US$ 157.5 Bn by 2027
MHealth Monitoring Diagnostic Medical Devices Market to Reach US$ 157.5 Bn by 2027
/PRNewswire/ -- Telememory Holding Corp., the makers of MoodSpark, has purchased Dthera Sciences, a pioneer in the digital therapeutics industry and leader in...
/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...